Yüklüyor......
New anticoagulants in atrial fibrillation: an update for clinicians
Anticoagulation is vital for stroke and systemic embolism prevention in patients with atrial fibrillation. Current therapy with the vitamin K inhibitor warfarin has many inherent limitations in clinical practice. With the potential of broadening anticoagulation therapy to a larger population, new cl...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513898/ https://ncbi.nlm.nih.gov/pubmed/23251767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622311424805 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|